160 related articles for article (PubMed ID: 9835534)
1. Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains.
Mimoz O; Jacolot A; Leotard S; Hidri N; Samii K; Nordmann P; Petitjean O
Antimicrob Agents Chemother; 1998 Dec; 42(12):3304-8. PubMed ID: 9835534
[TBL] [Abstract][Full Text] [Related]
2. Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae.
Mimoz O; Jacolot A; Padoin C; Tod M; Samii K; Petitjean O
J Antimicrob Chemother; 1998 Mar; 41(3):367-72. PubMed ID: 9578163
[TBL] [Abstract][Full Text] [Related]
3. Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae.
Mimoz O; Leotard S; Jacolot A; Padoin C; Louchahi K; Petitjean O; Nordmann P
Antimicrob Agents Chemother; 2000 Apr; 44(4):885-90. PubMed ID: 10722486
[TBL] [Abstract][Full Text] [Related]
4. Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo.
Mimoz O; Jacolot A; Padoin C; Caillon J; Louchahi K; Tod M; Samii K; Petitjean O
J Antimicrob Chemother; 1997 Mar; 39(3):363-9. PubMed ID: 9096186
[TBL] [Abstract][Full Text] [Related]
5. Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
Mimoz O; Elhelali N; Léotard S; Jacolot A; Laurent F; Samii K; Petitjean O; Nordmann P
J Antimicrob Chemother; 1999 Jul; 44(1):91-7. PubMed ID: 10459815
[TBL] [Abstract][Full Text] [Related]
6. Markedly different rates and resistance profiles exhibited by seven commonly used and newer beta-lactams on the selection of resistant variants of Enterobacter cloacae.
Chan WC; Li RC; Ling JM; Cheng AF; Schentag JJ
J Antimicrob Chemother; 1999 Jan; 43(1):55-60. PubMed ID: 10381101
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
Tessier F; Quentin C
Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
Szabó D; Máthé A; Filetóth Z; Anderlik P; Rókusz L; Rozgonyi F
Antimicrob Agents Chemother; 2001 Apr; 45(4):1287-91. PubMed ID: 11257049
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro bactericidal activity between cefepime and ceftazidime, alone and associated with amikacin, against carbapenem-resistant Pseudomonas aeruginosa strains.
Bantar C; Di Chiara M; Nicola F; Relloso S; Smayevsky J
Diagn Microbiol Infect Dis; 2000 May; 37(1):41-4. PubMed ID: 10794939
[TBL] [Abstract][Full Text] [Related]
10. Comparison of five beta-lactam antibiotics against common nosocomial pathogens using the time above MIC at different creatinine clearances.
Kays MB
Pharmacotherapy; 1999 Dec; 19(12):1392-9. PubMed ID: 10600088
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of ceftazidime, cefepime and imipenem on 1,005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to beta-lactams.
Bonfiglio G; Marchetti F
Chemotherapy; 2000; 46(4):229-34. PubMed ID: 10859428
[TBL] [Abstract][Full Text] [Related]
12. Development of resistance during ceftazidime and cefepime therapy in a murine peritonitis model.
Pechère JC; Vladoianu IR
J Antimicrob Chemother; 1992 May; 29(5):563-73. PubMed ID: 1624394
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro interactions of ceftazidime, meropenem, and imipenem with amikacin on multiresistant Pseudomonas aeruginosa.
Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H
Diagn Microbiol Infect Dis; 1997 Oct; 29(2):81-6. PubMed ID: 9368083
[TBL] [Abstract][Full Text] [Related]
14. Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
Jones RN; Salazar JC; Pfaller MA; Doern GV
Diagn Microbiol Infect Dis; 1997 Dec; 29(4):265-72. PubMed ID: 9458984
[TBL] [Abstract][Full Text] [Related]
15. The pharmacodynamics of avibactam in combination with ceftaroline or ceftazidime against β-lactamase-producing Enterobacteriaceae studied in an in vitro model of infection.
MacGowan A; Tomaselli S; Noel A; Bowker K
J Antimicrob Chemother; 2017 Mar; 72(3):762-769. PubMed ID: 28039276
[TBL] [Abstract][Full Text] [Related]
16. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
[TBL] [Abstract][Full Text] [Related]
17. SHV-12 extended spectrum beta-lactamase associated with high-level ceftazidime resistance in Enterobacter cloacae isolated from Thailand.
Tansawai U; Boonkerd N; Polwichai P; Dejsirilert S; Niumsup PR
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):148-54. PubMed ID: 19323047
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Zhao C; Xie W; Zhang W; Ye Z; Wu H
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
[TBL] [Abstract][Full Text] [Related]
19. Animal model methodology: immunocompetent or leucopenic rats, which is the best? Results from a model of experimental pneumonia due to derepressed cephalosporinase-producing Enterobacter cloacae.
Jacolot A; Judel C; Chaumais MC; Louchahi K; Nicolas P; Marchand S; Petitjean O; Mimoz O
Chemotherapy; 2012; 58(2):129-33. PubMed ID: 22572147
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.
Jones RN; Marshall SA
Diagn Microbiol Infect Dis; 1994 May; 19(1):33-8. PubMed ID: 7956010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
